CSIMarket
 
Seres Therapeutics Inc   (NASDAQ: MCRB)
 

Seres Therapeutics Inc's Suppliers Performance

MCRB's Supply Chain




 
MCRB Costs vs Sales of Suppliers Growth

• More on MCRB Suppliers






Seres Therapeutics Inc's Comment on Supply Chain


The company employs scalable and transferable raw materials, process technologies, and analytical tests compliant with cGMP manufacturing. Its core processes include fermentation, purification, formulation, and analytical testing. Fermentation utilizes microscale screening to optimize bacterial strains and scale-up procedures, sourcing strains from unique research cell bank precursors. Purification begins at a small scale but is designed for scalability, focusing on oral dosage forms containing spores or live bacteria, which facilitates separation compared to parenteral biologics. Formulation development emphasizes oral delivery using approved excipients and preservatives to achieve stability with minimal cold-chain requirements. Analytical methods comprise proprietary microbiological, chemical, biochemical, and molecular sequence-based tests to verify quality control, identity, potency, and purity. Manufacturing operations are based in Cambridge, Massachusetts.

Seres Therapeutics Inc's Comment on Supply Chain


The company employs scalable and transferable raw materials, process technologies, and analytical tests compliant with cGMP manufacturing. Its core processes include fermentation, purification, formulation, and analytical testing. Fermentation utilizes microscale screening to optimize bacterial strains and scale-up procedures, sourcing strains from unique research cell bank precursors. Purification begins at a small scale but is designed for scalability, focusing on oral dosage forms containing spores or live bacteria, which facilitates separation compared to parenteral biologics. Formulation development emphasizes oral delivery using approved excipients and preservatives to achieve stability with minimal cold-chain requirements. Analytical methods comprise proprietary microbiological, chemical, biochemical, and molecular sequence-based tests to verify quality control, identity, potency, and purity. Manufacturing operations are based in Cambridge, Massachusetts.







MCRB's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Seres Therapeutics Inc 34.31 1.88 -22.46 66
SUBTOTAL 0.00 0.00 0.00 -


Sources: Seres Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Seres Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.